North America Postmenopausal Vaginal Atrophy Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
124 Pages
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.


Scope of the Report:
This report focuses on the Postmenopausal Vaginal Atrophy Treatment in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Allergan
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Creams
Tablets
Patches
Rings

Market Segment by Applications, can be divided into
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy

There are 15 Chapters to deeply display the North America Postmenopausal Vaginal Atrophy Treatment market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Treatment Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Postmenopausal Vaginal Atrophy Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Postmenopausal Vaginal Atrophy Treatment, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Postmenopausal Vaginal Atrophy Treatment market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Postmenopausal Vaginal Atrophy Treatment Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents
1 Market Overview
1.1 Postmenopausal Vaginal Atrophy Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Creams
1.2.2 Tablets
1.2.3 Patches
1.2.4 Rings
1.3 Market Analysis by Applications
1.3.1 Topical Estrogen
1.3.2 Systemic Estrogen
1.3.3 Non-hormonal Therapy
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Profile
2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Pfizer News
2.2 Allergan
2.2.1 Profile
2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Allergan News
2.3 Shionogi
2.3.1 Profile
2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Shionogi News
2.4 Novo Nordisk
2.4.1 Profile
2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Novo Nordisk News
2.5 Teva Pharmaceutical
2.5.1 Profile
2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teva Pharmaceutical News
2.6 Bayer.
2.6.1 Profile
2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Bayer. News
3 North America Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer
3.1 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.5 Market Competition Trend
4 North America Postmenopausal Vaginal Atrophy Treatment Market Analysis by Countries
4.1 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries
4.2 North America Postmenopausal Vaginal Atrophy Treatment Sales by Countries (2012-2017)
4.3 North America Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type
5.1 North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
5.1.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
5.2 Creams Sales Growth and Price
5.2.1 North America Creams Sales Growth (2012-2017)
5.2.2 North America Creams Price (2012-2017)
5.3 Tablets Sales Growth and Price
5.3.1 North America Tablets Sales Growth (2012-2017)
5.3.2 North America Tablets Price (2012-2017)
5.4 Patches Sales Growth and Price
5.4.1 North America Patches Sales Growth (2012-2017)
5.4.2 North America Patches Price (2012-2017)
5.5 Rings Sales Growth and Price
5.5.1 North America Rings Sales Growth (2012-2017)
5.5.2 North America Rings Price (2012-2017)
6 North America Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application
6.1 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
6.2 Topical Estrogen Sales Growth (2012-2017)
6.3 Systemic Estrogen Sales Growth (2012-2017)
6.4 Non-hormonal Therapy Sales Growth (2012-2017)
7 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
7.3 United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
7.4 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer
7.4.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer
7.5 United States Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
8 Canada Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
8.3 Canada Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
8.4 Canada Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer
8.4.2 Canada Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer
8.5 Canada Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
9 Mexico Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
9.3 Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
9.4 Mexico Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer
9.4.2 Mexico Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer
9.5 Mexico Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
10 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022)
10.1 North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)
10.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Countries (2017-2022)
10.2.1 United States Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)
10.2.2 Canada Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)
10.2.3 Mexico Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)
10.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022)
10.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022)
11 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis
11.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


List of Tables and Figures

Figure Postmenopausal Vaginal Atrophy Treatment Picture
Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment
Figure North America Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016
Table Types of Postmenopausal Vaginal Atrophy Treatment
Figure Creams Picture
Table Major Manufacturers of Creams
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Patches Picture
Table Major Manufacturers of Patches
Figure Rings Picture
Table Major Manufacturers of Rings
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
Table Applications of Postmenopausal Vaginal Atrophy Treatment
Figure Topical Estrogen Picture
Figure Systemic Estrogen Picture
Figure Non-hormonal Therapy Picture
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer. Basic Information, Manufacturing Base and Competitors
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017
Table North America Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)
Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016
Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017
Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016
Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Countries (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries (2012-2017)
Figure North America 2012 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries
Figure North America 2016 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Countries (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries (2012-2017)
Table North America 2012 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries
Table North America 2016 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Share by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue Share by Type (2012-2017)
Figure North America Creams Sales Growth (2012-2017)
Figure North America Creams Price (2012-2017)
Figure North America Tablets Sales Growth (2012-2017)
Figure North America Tablets Price (2012-2017)
Figure North America Patches Sales Growth (2012-2017)
Figure North America Patches Price (2012-2017)
Figure North America Rings Sales Growth (2012-2017)
Figure North America Rings Price (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Share by Application (2012-2017)
Figure North America Topical Estrogen Sales Growth (2012-2017)
Figure North America Systemic Estrogen Sales Growth (2012-2017)
Figure North America Non-hormonal Therapy Sales Growth (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017
Table United States Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016
Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017
Table Canada Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016
Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017
Table Canada Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017
Table Mexico Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017
Table Mexico Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Countries (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Countries (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)
Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)
Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Type (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)
Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment
Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016
Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Scoop Stretcher Market 2017 Forecast to 2022

GIR 2017-11-24 Pharma & Healthcare

The scoop stretcher (or clamshell, Roberson orthopedic stretcher, or just scoop) is a device used sp...Read More

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Metal Biliary Stent Market 2017 Forecast to 2022

GIR 2017-11-24 Pharma & Healthcare

The most common indication for biliary stenting is for treatment of obstructive jaundice from either...Read More

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Laboratory Furniture Market 2017 Forecast to 2022

GIR 2017-11-24 Pharma & Healthcare

Laboratory Furniture is a kind of equipment used for working in Laboratory. Scope of the Report:
...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.